Tadaki Suzuki

16.8k citations

224 papers · 6.3k indexed · 3 hit papers · h-index 39

Co-authors: Hideki Hasegawa Hirofumi Sawa Akira Ainai Noriyo Nagata Yasuko Orba Makoto Takeda Kenichi Niikura Makoto Kuroda
Topics: SARS-CoV-2 and COVID-19 Research (61 papers)COVID-19 Clinical Research Studies (49 papers)Influenza Virus Research Studies (34 papers)
Cited by: Infectious Diseases Immunology Epidemiology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: Japan United States Mongolia

In The Last Decade

Tadaki Suzuki

207 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

2020 899 citations Shinji Saito, Noriyo Nagata et al. profile →
Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo

2013 524 citations Kenichi Niikura, Tadaki Suzuki et al. profile →
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

2021 310 citations Seiya Ozono, Kaori Sano et al. Nature Communications profile →

Peers

Countries citing papers authored by Tadaki Suzuki

Since Specialization

Citations

This map shows the geographic impact of Tadaki Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadaki Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadaki Suzuki more than expected).

Fields of papers citing papers by Tadaki Suzuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadaki Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadaki Suzuki. The network helps show where Tadaki Suzuki may publish in the future.

Co-authorship network of co-authors of Tadaki Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Tadaki Suzuki. A scholar is included among the top collaborators of Tadaki Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadaki Suzuki. Tadaki Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Duration of infectious virus shedding of SARS-CoV-2 Omicron variant among immunocompromised patients 2025 ·Journal of Infection and Chemotherapy ·(unknown),Naoya Itoh,Masahiro Ishikane,Noriko Iwamoto,Yusuke Asai,(unknown),(unknown),(unknown),Masayuki Hojo,Akira Hangaishi,Tomiteru Togano,Katsuji Teruya,Kenichiro Takahashi,Shô Miyamoto,Yuichiro Hirata,Takayuki Kanno,Tomoya Saito,Harutaka Katano,Tadaki Suzuki,Norio Ohmagari	2
2	Comparison of Infection-Induced SARS-CoV-2 Seroprevalence Across Large-Scale Residual Samples From Blood Donors, Commercial Laboratories, and Health Checkups in Japan, 2023 2025 ·Open Forum Infectious Diseases ·(unknown),Ryo Kinoshita,(unknown),(unknown),Tadaki Suzuki,Motoi Suzuki,Daisuke Yoneoka	0
3	Development of a Mouse-Adapted Reporter SARS-CoV-2 as a Tool for Two-Photon In Vivo Imaging 2024 ·Viruses ·Hiroshi Ueki,Maki Kiso,Yuri Furusawa,Shun Iida,Seiya Yamayoshi,Noriko Nakajima,Masaki Imai,Tadaki Suzuki,Yoshihiro Kawaoka	2
4	In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir 2023 ·Nature Communications ·Maki Kiso,Seiya Yamayoshi,Shun Iida,Yuri Furusawa,Yuichiro Hirata,Ryuta Uraki,Masaki Imai,Tadaki Suzuki,Yoshihiro Kawaoka	38
5	High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection 2023 ·Biochemical and Biophysical Research Communications ·(unknown),Yu Adachi,Taishi Onodera,(unknown),Naoko Iwata‐Yoshikawa,Noriyo Nagata,Tadaki Suzuki,Shinji Takeoka,Yoshimasa Takahashi	0
6	Macacine alphaherpesvirus 1 (B Virus) Infection in Humans, Japan, 2019 2023 ·Emerging infectious diseases ·Souichi Yamada,Harutaka Katano,Yuko Sato,Tadaki Suzuki,Akihiko Uda,Keita Ishijima,Motoi Suzuki,(unknown),Shizuko Harada,Hitomi Kinoshita,(unknown),Hideki Ebihara,Ken Maeda,Masayuki Saijo,(unknown)	2
7	Genomic analysis of SARS‐CoV‐2 in forensic autopsy cases of COVID‐19 2023 ·Journal of Medical Virology ·Yuichiro Hirata,Harutaka Katano,Shun Iida,Sohtaro Mine,Sayaka Nagasawa,Yohsuke Makino,Ayumi Motomura,Seiya Ozono,Yuko Sato,Tsuyoshi Sekizuka,Makoto Kuroda,Rutsuko Yamaguchi,Go Inokuchi,Suguru Torimitsu,(unknown),Daisuke Yajima,Hisako Saitoh,Tadaki Suzuki,Hirotaro Iwase	1
8	A nationwide cross-sectional study using a web-based questionnaire survey of the duration of isolation of COVID-19 inpatients with cancer at Japanese cancer centers 2023 ·Journal of Infection and Chemotherapy ·Naoya Itoh,(unknown),Hanako Kurai,Ichiro Kawamura,Keiji Okinaka,Takahiro Fujita,Noritaka Sekiya,Koichi Takeda,(unknown),Masahiro Ishikane,Noriko Iwamoto,Norio Ohmagari,Tadaki Suzuki	1
9	A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection 2022 ·Science Advances ·Naoko Iwata‐Yoshikawa,(unknown),Tsuyoshi Sekizuka,Kaori Sano,Akira Ainai,(unknown),Michiyo Kataoka,Makoto Kuroda,Hideki Hasegawa,Tadaki Suzuki,Noriyo Nagata	31
10	Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model 2022 ·mBio ·S. Chiba,Maki Kiso,Noriko Nakajima,Shun Iida,Tadashi Maemura,Makoto Kuroda,Yuko Sato,Mutsumi Ito,Moe Okuda,S. Yamada,Kiyoko Iwatsuki‐Horimoto,Tokiko Watanabe,Masaki Imai,Tammy Armbrust,Ralph S. Baric,Peter Halfmann,Tadaki Suzuki,Yoshihiro Kawaoka	23
11	Reverse Genetics System for Heartland Bandavirus: NSs Protein Contributes to Heartland Bandavirus Virulence 2022 ·Journal of Virology ·Satoshi Taniguchi,Takuya Inagaki,Shigeru Tajima,Tadaki Suzuki,Tomoki Yoshikawa,Shuetsu Fukushi,Eun‐Sil Park,H Fujii,Shigeru Morikawa,Hideki Tani,Eri Nakayama,Takahiro Maeki,Masayuki Shimojima,Chang‐Kweng Lim,Masayuki Saijo	10
12	Severe Fever with Thrombocytopenia Syndrome Accompanied by Invasive Pulmonary Aspergillosis: An Autopsy Case 2021 ·Viruses ·(unknown),Takeshi Kawaguchi,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Ichiro Takajo,(unknown),Tsuyoshi Fukushima,Hiroaki Kataoka,Tadaki Suzuki,Akihiko Okayama,Kunihiko Umekita	13
13	Suberoyl Bis-Hydroxamic Acid Reactivates Kaposi’s Sarcoma-Associated Herpesvirus through Histone Acetylation and Induces Apoptosis in Lymphoma Cells 2020 ·Journal of Virology ·Shun Iida,Sohtaro Mine,Keiji Ueda,Tadaki Suzuki,Hideki Hasegawa,Harutaka Katano	5
14	Characterization of pseudotyped vesicular stomatitis virus bearing the heartland virus envelope glycoprotein 2020 ·Virology ·Miyuki Kimura,(unknown),Tatsuhiko Ozawa,Hiroyuki Kishi,Masayuki Shimojima,Satoshi Taniguchi,Shuetsu Fukushi,H Fujii,Hiroshi Yamada,Long Tan,Kaori Sano,Harutaka Katano,Tadaki Suzuki,Shigeru Morikawa,Masayuki Saijo,Hideki Tani	11
15	Gold nanoparticle‐adjuvanted S protein induces a strong antigen‐specific IgG response against severe acute respiratory syndrome‐related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs 2019 ·Microbiology and Immunology ·(unknown),Naoko Iwata‐Yoshikawa,Shuetsu Fukushi,Hideki Tani,Michiyo Kataoka,Tadaki Suzuki,Hideki Hasegawa,Kenichi Niikura,Katsuhiko Arai,Noriyo Nagata	124
16	Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing 2019 ·Journal of Visualized Experiments ·(unknown),Naoko Kono,Hiroyuki Toh,(unknown),Kaori Sano,Tadaki Suzuki,(unknown),(unknown),(unknown),Hideki Hasegawa,Yoshimasa Takahashi,Shigeyuki Itamura,Kazuo Ohnishi	2
17	Cutaneous histopathology of the tick‐bite region in severe fever with thrombocytopenia syndrome 2019 ·The Journal of Dermatology ·(unknown),Haruto Nishida,Mizuki Goto,(unknown),(unknown),Tsutomu Daa,Shigeo Yokoyama,(unknown),Osamu Matsunari,Teruo Sakamoto,Hiroyuki Matsumoto,Tadaki Suzuki,Hideki Hasegawa,Naoko Takeo,Yutaka Hatano	6
18	IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration 2018 ·Human Vaccines & Immunotherapeutics ·(unknown),Kaori Sano,Akira Ainai,Shinji Saito,Yuki Taga,Kiyoko Ogawa‐Goto,Shinichi Tamura,Takato Odagiri,Masato Tashiro,Mikiya Fujieda,Tadaki Suzuki,Hideki Hasegawa	41
19	Inhibitory effects of an M2-specific monoclonal antibody on different strains of influenza A virus. 2012 ·PubMed ·(unknown),Reiko Yoshida,Tadaki Suzuki,Shintaro Kobayashi,Hiroichi Ozaki,Daisuke Fujikura,Rashid Manzoor,Mieko Muramatsu,Ayato Takada,Takashi Kimura,Hirofumi Sawa	10
20	Oligodendrocyte Lineage Transcription Factor 2 Inhibits the Motility of a Human Glial Tumor Cell Line by Activating RhoA 2007 ·Molecular Cancer Research ·Kouichi Tabu,Yusuke Ohba,Tadaki Suzuki,Yoshinori Makino,Taichi Kimura,Akiko Ohnishi,(unknown),Takuya Watanabe,Shinya Tanaka,Hirofumi Sawa	21

About Tadaki Suzuki

Tadaki Suzuki is a scholar working on Infectious Diseases, Immunology and Epidemiology, having authored 224 papers that have together received 6.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (61 papers), COVID-19 Clinical Research Studies (49 papers) and Influenza Virus Research Studies (34 papers). The work is most often cited by research in Infectious Diseases (3.3k citations), Immunology (1.3k citations) and Epidemiology (1.5k citations). Tadaki Suzuki has collaborated with scholars based in Japan, United States and Mongolia. Frequent co-authors include Hideki Hasegawa, Hirofumi Sawa, Akira Ainai, Noriyo Nagata, Yasuko Orba, Makoto Takeda, Kenichi Niikura, Makoto Kuroda, Yuko Sato and Tsuyoshi Sekizuka. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact